New Inhibitors for Trypanosoma brucei Pteridine Reductase 1
Author Information
Author(s): Daniel Spinks, Han B Mpamhanga, Chidochangu P Shanks, Emma J Robinson, David A Collie, Iain T Read, Kevin D Frearson, Julie A Wyatt, Paul G Brenk, Ruth Fairlamb, Alan H Gilbert, Ian H Gilbert
Primary Institution: University of Dundee
Hypothesis
Can novel inhibitors of PTR1 effectively target Trypanosoma brucei?
Conclusion
The developed PTR1 inhibitors showed high selectivity but weak activity against the parasites.
Supporting Evidence
- PTR1 is essential for the survival of Trypanosoma brucei.
- The inhibitors were discovered through virtual screening.
- Compounds showed high selectivity over human dihydrofolate reductase.
- Despite potent enzyme inhibition, no significant activity against the parasites was observed.
- Compounds had reasonable properties for cellular penetration.
Takeaway
Scientists created new drugs to fight a parasite that causes sleeping sickness, but these drugs didn't work well in tests.
Methodology
The study involved designing and testing a series of PTR1 inhibitors using structure-based drug design and medicinal chemistry.
Limitations
The inhibitors displayed weak activity against the parasites despite having potent enzyme inhibition.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website